PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery M Ogris, S Brunner, S Schüller, R Kircheis, E Wagner Gene therapy 6 (4), 595-605, 1999 | 1576 | 1999 |
Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo L Wightman, R Kircheis, V Rössler, S Carotta, R Ruzicka, M Kursa, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2001 | 932 | 2001 |
Design and gene delivery activity of modified polyethylenimines R Kircheis, L Wightman, E Wagner Advanced drug delivery reviews 53 (3), 341-358, 2001 | 901 | 2001 |
The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells M Ogris, P Steinlein, M Kursa, K Mechtler, R Kircheis, E Wagner Gene therapy 5 (10), 1425-1433, 1998 | 794 | 1998 |
Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery R Kircheis, A Kichler, G Wallner, M Kursa, M Ogris, T Felzmann, ... Gene therapy 4 (5), 409-418, 1997 | 529 | 1997 |
Polycation‐based DNA complexes for tumor‐targeted gene delivery in vivo R Kircheis, S Schüller, S Brunner, M Ogris, KH Heider, W Zauner, ... The journal of gene medicine 1 (2), 111-120, 1999 | 526 | 1999 |
Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application R Kircheis, L Wightman, A Schreiber, B Robitza, V Rössler, M Kursa, ... Gene therapy 8 (1), 28-40, 2001 | 488 | 2001 |
Novel shielded transferrin− polyethylene glycol− polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer M Kursa, GF Walker, V Roessler, M Ogris, W Roedl, R Kircheis, E Wagner Bioconjugate chemistry 14 (1), 222-231, 2003 | 431 | 2003 |
Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes M Ogris, G Walker, T Blessing, R Kircheis, M Wolschek, E Wagner Journal of Controlled Release 91 (1-2), 173-181, 2003 | 398 | 2003 |
Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery T Blessing, M Kursa, R Holzhauser, R Kircheis, E Wagner Bioconjugate chemistry 12 (4), 529-537, 2001 | 355 | 2001 |
Cancer immunotherapy M Schuster, A Nechansky, R Kircheis Biotechnology Journal: Healthcare Nutrition Technology 1 (2), 138-147, 2006 | 286 | 2006 |
Tumor targeting with surface-shielded ligand–polycation DNA complexes R Kircheis, T Blessing, S Brunner, L Wightman, E Wagner Journal of controlled release 72 (1-3), 165-170, 2001 | 234 | 2001 |
NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients R Kircheis, E Haasbach, D Lueftenegger, WT Heyken, M Ocker, O Planz Frontiers in immunology 11, 598444, 2020 | 192 | 2020 |
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice MF Wolschek, C Thallinger, M Kursa, V Rössler, M Allen, C Lichtenberger, ... Hepatology 36 (5), 1106-1114, 2002 | 155 | 2002 |
Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity R Kircheis, E Ostermann, MF Wolschek, C Lichtenberger, ... Cancer gene therapy 9 (8), 673-680, 2002 | 131 | 2002 |
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the … S Finke, B Trojaneck, P Lefterova, M Csipai, E Wagner, R Kircheis, ... Gene therapy 5 (1), 31-39, 1998 | 114 | 1998 |
Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function B Antes, S Amon, A Rizzi, S Wiederkum, M Kainer, O Szolar, M Fido, ... Journal of chromatography b 852 (1-2), 250-256, 2007 | 108 | 2007 |
Polymeric gene delivery: principles and applications MM Amiji CRC press, 2004 | 108 | 2004 |
Targeted nucleic acid delivery into tumors: new avenues for cancer therapy E Wagner, R Kircheis, GF Walker Biomedicine & pharmacotherapy 58 (3), 152-161, 2004 | 99 | 2004 |
Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment R Kircheis, L Wightman, M Kursa, E Ostermann, E Wagner Gene therapy 9 (11), 731-735, 2002 | 91 | 2002 |